Admedus Ltd – Strategy, SWOT and Corporate Finance Report

Admedus Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue repairs. Its flagship product, CardioCel is a regenerative tissue for cardiac repairs and reconstructions. The company also distributes infusion systems including ambulatory pumps, syringe and volumetric pumps, administration accessories, Amnicot finger cot, nasal spray (PCA) device and O’Neil urinary catheters. Admedus is developing next generation vaccines for the treatment and prevention of infectious diseases and cancers with an initial focus on Herpes Simplex Virus (HSV-2) and Human papillomavirus (HPV). Admedus is headquartered in Malaga, Western Australia, Australia.

Scope

Detailed information on Admedus Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Admedus Ltd in the form of a SWOT analysis

An in-depth view of the business model of Admedus Ltd including a breakdown and examination of key business segments

News about Admedus Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Admedus Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Admedus Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Admedus Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Nexstim Plc

Medtronic Australasia Pty Ltd

Biotron Ltd

Benitec Biopharma Ltd

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Admedus Ltd - Key Facts 5

Admedus Ltd - Key Employees 6

Admedus Ltd - Key Employee Biographies 7

Admedus Ltd - Major Products and Services 8

Admedus Ltd - History 9

Admedus Ltd - Company Statement 11

Admedus Ltd - Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2 Company Analysis 14

Company Overview 14

Admedus Ltd - Business Description 15

Admedus Ltd - SWOT Analysis 16

SWOT Analysis - Overview 16

Admedus Ltd - Strengths 16

Admedus Ltd - Weaknesses 17

Admedus Ltd - Opportunities 18

Admedus Ltd - Threats 19

Admedus Ltd - Key Competitors 20

Section 3 Company Financial Ratios 21

Financial Ratios - Capital Market Ratios 21

Financial Ratios - Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios - Interim Ratios 25

Financial Ratios - Ratio Charts 26

Section 4 Company’s Lifesciences Financial Deals and Alliances 27

Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 27

Admedus Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018 28

Admedus Ltd, Recent Deals Summary 29

Section 5 Company’s Recent Developments 30

Dec 12, 2018: Admedus: Board of directors appointments 30

Dec 04, 2018: Admedus names Dr Kiran Bhirangi as Chief Medical Officer 31

Nov 26, 2018: Admedus technology names Matthew Mcdonnell as interim CFO 32

Nov 19, 2018: Admedus: restructure of Australian management team 33

Oct 29, 2018: Admedus: Director resignation 34

Oct 04, 2018: Admedus announces Non-Executive Director resignation and appointment 35

Aug 09, 2018: Admedus: Distribution agreement renewed for infusion supply chain 36

Jul 31, 2018: Admedus: Quarterly report Appendix 4C for the period to 30 June 2018 37

Jun 06, 2018: Admedus Announces Conclusion Of Relationship With Go Medical 41

May 23, 2018: Admedus Announce Appointment of Catherine Costello 42

Section 6 Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Tables

List of Tables

Admedus Ltd, Key Facts 5

Admedus Ltd, Key Employees 6

Admedus Ltd, Key Employee Biographies 7

Admedus Ltd, Major Products and Services 8

Admedus Ltd, History 9

Admedus Ltd, Other Locations 13

Admedus Ltd, Subsidiaries 13

Admedus Ltd, Key Competitors 20

Admedus Ltd, Ratios based on current share price 21

Admedus Ltd, Annual Ratios 22

Admedus Ltd, Annual Ratios (Cont…1) 23

Admedus Ltd, Interim Ratios 25

Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 27

Admedus Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018 28

Admedus Ltd, Recent Deals Summary 29

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

List of Figures

List of Figures

Admedus Ltd, Performance Chart (2013 – 2017) 24

Admedus Ltd, Ratio Charts 26

Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 27

Admedus Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 28

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports